黄天健, 陈佳英, 喻江婷, 周一鸣, 许雷来, 顾锡冬. 发酵乳杆菌 CECT5716 联合阳和汤治疗阴证非哺乳期乳腺炎临床观察. 2026. biomedRxiv.202601.00023
发酵乳杆菌 CECT5716 联合阳和汤治疗阴证非哺乳期乳腺炎临床观察
通讯作者: 顾锡冬, guxidong@163.com
DOI:10.12201/bmr.202601.00023
Huang Tianjian1, Chen Jiaying1, Yu Jiangting1, Zhou Yiming1, Xu Leilai2, Gu Xidong21Zhejiang Chinese Medical University, Hangzhou 310053, China; 2The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, China
Corresponding author: GUXIDONG, guxidong@163.com
-
摘要:目的观察发酵乳杆菌 CECT5716 联合阳和汤治疗阴证非哺乳期乳腺炎(NLM)的临床疗效。方法 选取 2023 年 4 月至 2024 年 12 月浙江中医药大学附属第一医院收治的阴证非哺乳期乳腺炎患者 42 例作为研究对象,联合组 22 例采用发酵乳杆菌 CECT5716 联合阳和汤治疗,中药组 20 例采用单纯阳和汤治疗,12 周为 1 个疗程。比较两组患者的 SF-36 生活质量量表评分、中医证候评分、肉芽肿性小叶性乳腺炎疾病活动指数(GDMAI)及治疗有效率。结果 治疗后两组患者的 SF-36 生活质量评分、中医证候评分、GDMAI 均较治疗前明显改善,且联合组患者的躯体健康所致角色限制(RP)评分、社交功能(SF)评分、中医证候得分减少百分比及肿块质地改善程度较中药组更显著(P<0.05)。治疗后,联合组患者的治疗有效率(73.0%)明显高于中药组(60.0%),差异有统计学意义(P<0.05)。结论 发酵乳杆菌 CECT5716 联合阳和汤治疗可显著改善阴证非哺乳期乳腺炎患者的生活质量,减轻临床症状,提升治疗有效率,效果优于单纯中药治疗,值得临床推广应用。
Abstract: Objective: To observe the clinical efficacy of Lactobacillus fermentum CECT5716 combined with Yanghe Decoction in the treatment of Yin syndrome non-lactating mastitis (NLM). Methods: A total of 42 patients with Yin syndrome non-lactating mastitis admitted to The First Affiliated Hospital of Zhejiang Chinese Medical University from April 2023 to December 2024 were selected as the research objects. They were divided into two groups: the combined group (22 cases) treated with Lactobacillus fermentum CECT5716 combined with Yanghe Decoction, and the TCM group (20 cases) treated with Yanghe Decoction alone. A 12-week period was set as one course of treatment. The SF-36 Quality of Life Scale scores, TCM syndrome scores, Granulomatous Lobular Mastitis Disease Activity Index (GDMAI), and treatment effective rate were compared between the two groups. Results: After treatment, the SF-36 Quality of Life Scale scores, TCM syndrome scores, and GDMAI of patients in both groups were significantly improved compared with those before treatment. Moreover, the Role Limitations due to Physical Health (RP) scores, Social Functioning (SF) scores, percentage reduction of TCM syndrome scores, and improvement of lump texture in the combined group were more significant than those in the TCM group (P<0.05). After treatment, the treatment effective rate of the combined group (73.0%) was significantly higher than that of the TCM group (60.0%), and the difference was statistically significant (P<0.05). Conclusion: Lactobacillus fermentum CECT5716 combined with Yanghe Decoction can significantly improve the quality of life, alleviate clinical symptoms, and increase the treatment effective rate of patients with Yin syndrome non-lactating mastitis. Its effect is better than that of TCM treatment alone, and it is worthy of clinical promotion and application.
Key words: Non-lactating Mastitis; Lactobacillus fermentum CECT5716; Yanghe Decoction; Yin Syndrome; Clinical Observation提交时间:2026-01-09
版权声明:作者本人独立拥有该论文的版权,预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。 -
图表
-
项云, 谢春红, 苏元晖, 陈兴, 杨兵, 聂艳琴, 张惠菊, 黄连江. 一例克氏棒状杆菌引起的非哺乳期乳腺炎并文献复习. 2024. doi: 10.12201/bmr.202412.00031
常丹阳, 方桂珍. 中西医治疗非哺乳期乳腺炎研究进展. 2024. doi: 10.12201/bmr.202407.00007
李筱琳, 隋欣, 宋娟, 包亚男, 林宇, 满子腾, 程甜甜, 杨宏艳. 基于WGCNA鉴定阿尔茨海默病的衰老关键基因. 2024. doi: 10.12201/bmr.202407.00036
肖桐, 陈海涛, 张尊敬. 宣肺利咽汤治疗感染后咳嗽风热犯肺证临床观察. 2024. doi: 10.12201/bmr.202408.00008
李娜, 罗炳清. 微波消融联合化疗+PD-1抑制剂治疗非小细胞肺癌的临床观察. 2025. doi: 10.12201/bmr.202504.00054
张捷荣, 龙媛媛, 蒲佳乐, 张曾宇, 沈子豪, 张冀东. 诱导巨噬细胞极化在炎症消退期应用前景分析. 2024. doi: 10.12201/bmr.202409.00005
谢文佳, 倪佳宁, 周舒燕, 章婷婷, 蔡旭东. 中西结合慢性肾脏病管理对CKD3-5期非透析患者临床应用观察. 2024. doi: 10.12201/bmr.202409.00065
杨庆松, 张燕洁, 刘燕, 刘振. 加味散偏汤治疗肝郁血瘀型紧张型头痛临床观察. 2024. doi: 10.12201/bmr.202412.00019
赵君, 刘思琦, 袁莎莎, 路海英, 黄洁, 王钰东, 王芳. 我国居家社区医养结合服务人力政策分析. 2023. doi: 10.12201/bmr.202304.00010
周昕怡, 郑文兰, 田淑阳, 王劲瑶. 基于CiteSpace的中医药治疗功能失调性子宫出血可视化分析. 2025. doi: 10.12201/bmr.202507.00067
-
序号 提交日期 编号 操作 1 2025-11-27 10.12201/bmr.202601.00023V1
下载 -
-
公开评论 匿名评论 仅发给作者
引用格式
访问统计
- 阅读量:21
- 下载量: 0
- 评论数:0

登录
注册




京公网安备